Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces New CEO Investment December 24, 2025 Brunswick Exploration Closes Upsized Non-Brokered Private Placement of $2.1 M December 24, 2025 New Found Gold December 24, 2025
Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces New CEO Investment December 24, 2025